Subconjunctival Orbital Fat Prolapse: Diagnosis and Management

Background: Subconjunctival orbital fat prolapse is a benign condition and most patients who present with it are asymptomatic. Their main concern is the lesions\u27 cosmetic appearance. Many other potentially dangerous orbital pathologies can mimic subconjunctival orbital fat prolapse. The excised orbital fat needs to be evaluated histopathologically to rule-out any malignancy. Surgical repair is straight-forward and cosmetically satisfying to patients. Case Report: A 79-year-old male presented with subconjunctival orbital fat prolapse. He wanted the lesion removed for cosmetic reasons. The prolapsed orbital fat was excised successfully and histopathologic analysis confirmed the benign nature of his lesion. Conclusion: Optometrists should be aware of these unusual orbital lesions and refer the patient for surgical repair

Diagnosis and Excision of a Solitary Trichoepithelioma

Abstract Background: Solitary trichoepithelioma is a rare benign tumor of hair follicle origin. Although trichoepithelioma has a predilection for the face and neck, it is not usually found on the eyelids. It has similar clinicopathological features to basal cell carcinoma. Surgical excision and histopathologic analysis is helpful for correct diagnosis. Case Report: A 59-year-old Caucasian female presented with a raised, reddish oval mass on the right lower eyelid. The mass had telangiectatic blood vessels on its surface, was non-pigmented and slightly umbilicated. It was in close approximation of the eyelid margin causing distortion and poor apposition of the lid to the globe. The mass was completely removed under local anesthesia using the tissue-sparing surgical technique known as shave biopsy. Histopathologic analysis confirmed the mass to be a trichoepithelioma. Conclusion: Optometrists should be able to differentiate benign trichoepithelioma from basal cell carcinoma

Cefuroxime-Induced Toxic Maculopathy: A Cataract Co-Management Conundrum

Background: Cefuroxime-induced toxic maculopathy can occur when an incorrect dilution is injected intracamerally after cataract surgery. This results in a guarded visual prognosis. Cefuroxime-induced toxic maculopathy can also occur sporadically even when the medication dilution is the standard correct dosage. These patients usually recover their vision by the first postoperative week. Case Report: A 72-year-old Caucasian female developed cefuroxime-induced toxic maculopathy after uneventful cataract surgery. Investigation of the case confirmed that she had a sporadic response to the cefuroxime. It was verified that she received the standard correct dilution of cefuroxime intracamerally. The patient showed a significant improvement in her vision by her first postoperative weekly visit. By her last postoperative visit at 7 weeks her best corrected visual acuity was 20/20. Conclusion: Optometrists should be aware of cefuroxime-induced toxic maculopathy and distinguish between sporadic cases and those where the patient received an incorrect medication dilution dosage